A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma

Neil Ari Wijetunga, Miriam Ben-Dayan, Jessica Tozour, Robert D. Burk, Nicolas F. Schlecht, Mark H. Einstein, John M. Greally

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Human papillomavirus (HPV)-associated cervical carcinoma is preceded by stages of cervical intra-epithelial neoplasia (CIN) that can variably progress to malignancy. Understanding the different molecular processes involved in the progression of premalignant CIN is critical to the development of improved predictive and interventional capabilities. We tested the role of regulators of transcription in both the development and the progression of HPV-associated CIN, performing the most comprehensive genomic survey to date of DNA methylation in HPV-associated cervical neoplasia, testing ~2 million loci throughout the human genome in biopsies from 78 HPV+ women, identifying changes starting in early CIN and maintained through carcinogenesis. We identified loci at which DNA methylation is consistently altered, beginning early in the course of neoplastic disease and progressing with disease advancement. While the loss of DNA methylation occurs mostly at intergenic regions, acquisition of DNA methylation is at sites involved in transcriptional regulation, with strong enrichment for targets of polycomb repression. Using an independent cohort from The Cancer Genome Atlas, we validated the loci with increased DNA methylation and found that these regulatory changes were associated with locally decreased gene expression. Secondary validation using immunohistochemistry showed that the progression of neoplasia was associated with increasing polycomb protein expression specifically in the cervical epithelium. We find that perturbations of genomic regulatory processes occur early and persist in cervical carcinoma. The results indicate a polycombmediated epigenetic field defect in cervical neoplasia that may represent a target for early, topical interventions using polycomb inhibitors.

Original languageEnglish (US)
Pages (from-to)62133-62143
Number of pages11
JournalOncotarget
Volume7
Issue number38
DOIs
StatePublished - 2016

Fingerprint

Epigenomics
Carcinoma
DNA Methylation
Neoplasms
Intergenic DNA
Atlases
Human Development
Human Genome
Carcinogenesis
Epithelium
Immunohistochemistry
Genome
Biopsy
Gene Expression

Keywords

  • Cervical carcinoma
  • DNA methylation
  • Epigenetic
  • Field defect
  • Polycomb

ASJC Scopus subject areas

  • Oncology

Cite this

Wijetunga, N. A., Ben-Dayan, M., Tozour, J., Burk, R. D., Schlecht, N. F., Einstein, M. H., & Greally, J. M. (2016). A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma. Oncotarget, 7(38), 62133-62143. https://doi.org/10.18632/oncotarget.11390

A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma. / Wijetunga, Neil Ari; Ben-Dayan, Miriam; Tozour, Jessica; Burk, Robert D.; Schlecht, Nicolas F.; Einstein, Mark H.; Greally, John M.

In: Oncotarget, Vol. 7, No. 38, 2016, p. 62133-62143.

Research output: Contribution to journalArticle

Wijetunga, NA, Ben-Dayan, M, Tozour, J, Burk, RD, Schlecht, NF, Einstein, MH & Greally, JM 2016, 'A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma', Oncotarget, vol. 7, no. 38, pp. 62133-62143. https://doi.org/10.18632/oncotarget.11390
Wijetunga NA, Ben-Dayan M, Tozour J, Burk RD, Schlecht NF, Einstein MH et al. A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma. Oncotarget. 2016;7(38):62133-62143. https://doi.org/10.18632/oncotarget.11390
Wijetunga, Neil Ari ; Ben-Dayan, Miriam ; Tozour, Jessica ; Burk, Robert D. ; Schlecht, Nicolas F. ; Einstein, Mark H. ; Greally, John M. / A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma. In: Oncotarget. 2016 ; Vol. 7, No. 38. pp. 62133-62143.
@article{6a071446358546188b1c924f88570afc,
title = "A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma",
abstract = "Human papillomavirus (HPV)-associated cervical carcinoma is preceded by stages of cervical intra-epithelial neoplasia (CIN) that can variably progress to malignancy. Understanding the different molecular processes involved in the progression of premalignant CIN is critical to the development of improved predictive and interventional capabilities. We tested the role of regulators of transcription in both the development and the progression of HPV-associated CIN, performing the most comprehensive genomic survey to date of DNA methylation in HPV-associated cervical neoplasia, testing ~2 million loci throughout the human genome in biopsies from 78 HPV+ women, identifying changes starting in early CIN and maintained through carcinogenesis. We identified loci at which DNA methylation is consistently altered, beginning early in the course of neoplastic disease and progressing with disease advancement. While the loss of DNA methylation occurs mostly at intergenic regions, acquisition of DNA methylation is at sites involved in transcriptional regulation, with strong enrichment for targets of polycomb repression. Using an independent cohort from The Cancer Genome Atlas, we validated the loci with increased DNA methylation and found that these regulatory changes were associated with locally decreased gene expression. Secondary validation using immunohistochemistry showed that the progression of neoplasia was associated with increasing polycomb protein expression specifically in the cervical epithelium. We find that perturbations of genomic regulatory processes occur early and persist in cervical carcinoma. The results indicate a polycombmediated epigenetic field defect in cervical neoplasia that may represent a target for early, topical interventions using polycomb inhibitors.",
keywords = "Cervical carcinoma, DNA methylation, Epigenetic, Field defect, Polycomb",
author = "Wijetunga, {Neil Ari} and Miriam Ben-Dayan and Jessica Tozour and Burk, {Robert D.} and Schlecht, {Nicolas F.} and Einstein, {Mark H.} and Greally, {John M.}",
year = "2016",
doi = "10.18632/oncotarget.11390",
language = "English (US)",
volume = "7",
pages = "62133--62143",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "38",

}

TY - JOUR

T1 - A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma

AU - Wijetunga, Neil Ari

AU - Ben-Dayan, Miriam

AU - Tozour, Jessica

AU - Burk, Robert D.

AU - Schlecht, Nicolas F.

AU - Einstein, Mark H.

AU - Greally, John M.

PY - 2016

Y1 - 2016

N2 - Human papillomavirus (HPV)-associated cervical carcinoma is preceded by stages of cervical intra-epithelial neoplasia (CIN) that can variably progress to malignancy. Understanding the different molecular processes involved in the progression of premalignant CIN is critical to the development of improved predictive and interventional capabilities. We tested the role of regulators of transcription in both the development and the progression of HPV-associated CIN, performing the most comprehensive genomic survey to date of DNA methylation in HPV-associated cervical neoplasia, testing ~2 million loci throughout the human genome in biopsies from 78 HPV+ women, identifying changes starting in early CIN and maintained through carcinogenesis. We identified loci at which DNA methylation is consistently altered, beginning early in the course of neoplastic disease and progressing with disease advancement. While the loss of DNA methylation occurs mostly at intergenic regions, acquisition of DNA methylation is at sites involved in transcriptional regulation, with strong enrichment for targets of polycomb repression. Using an independent cohort from The Cancer Genome Atlas, we validated the loci with increased DNA methylation and found that these regulatory changes were associated with locally decreased gene expression. Secondary validation using immunohistochemistry showed that the progression of neoplasia was associated with increasing polycomb protein expression specifically in the cervical epithelium. We find that perturbations of genomic regulatory processes occur early and persist in cervical carcinoma. The results indicate a polycombmediated epigenetic field defect in cervical neoplasia that may represent a target for early, topical interventions using polycomb inhibitors.

AB - Human papillomavirus (HPV)-associated cervical carcinoma is preceded by stages of cervical intra-epithelial neoplasia (CIN) that can variably progress to malignancy. Understanding the different molecular processes involved in the progression of premalignant CIN is critical to the development of improved predictive and interventional capabilities. We tested the role of regulators of transcription in both the development and the progression of HPV-associated CIN, performing the most comprehensive genomic survey to date of DNA methylation in HPV-associated cervical neoplasia, testing ~2 million loci throughout the human genome in biopsies from 78 HPV+ women, identifying changes starting in early CIN and maintained through carcinogenesis. We identified loci at which DNA methylation is consistently altered, beginning early in the course of neoplastic disease and progressing with disease advancement. While the loss of DNA methylation occurs mostly at intergenic regions, acquisition of DNA methylation is at sites involved in transcriptional regulation, with strong enrichment for targets of polycomb repression. Using an independent cohort from The Cancer Genome Atlas, we validated the loci with increased DNA methylation and found that these regulatory changes were associated with locally decreased gene expression. Secondary validation using immunohistochemistry showed that the progression of neoplasia was associated with increasing polycomb protein expression specifically in the cervical epithelium. We find that perturbations of genomic regulatory processes occur early and persist in cervical carcinoma. The results indicate a polycombmediated epigenetic field defect in cervical neoplasia that may represent a target for early, topical interventions using polycomb inhibitors.

KW - Cervical carcinoma

KW - DNA methylation

KW - Epigenetic

KW - Field defect

KW - Polycomb

UR - http://www.scopus.com/inward/record.url?scp=84991773713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991773713&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.11390

DO - 10.18632/oncotarget.11390

M3 - Article

C2 - 27557505

AN - SCOPUS:84991773713

VL - 7

SP - 62133

EP - 62143

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 38

ER -